Related Topics



ICNMD 2018 Vienna, Austria

Genea Biocells exhibited at the International Congress for NeuroMuscular Diseases (ICNMD) in Vienna, Austria from July 6-10, 2018.  The organizers did an excellent job to accommodate about 1,500 delegates -...

Read More

ISSCR 2018-Melbourne, Australia

The International Society for Stem Cell Research (ISSCR) annual meeting was held June 20-23, in Melbourne, Australia. Roughly 3,000 attendees descended on Melbourne’s modern convention center - significantly down from...

Read More

Drug Repurposing in the 21st Century

Old for New: Drug Repurposing in the 21st Century   The attractiveness of repurposing The cost of finding, developing and achieving marketing approval for new, clinically effective drugs is immense and generally outside...

Read More

2018 FSHD Connect Mtg. Las Vegas

On June 8 & 9, 2018, scientific and medical researchers from academia and industry convened for the FSH Society’s 23rd annual International Research Conference (IRC) in Las Vegas, NV.  Genea...

Read More

Genea Gets Orphan Drug Designation

Genea Biocells Announces FDA Orphan Drug Designation for GBC0905 For The Treatment Of  Facioscapulohumeral Muscular Dystrophy (FSHD) San Diego (CA), May 30, 2018 -- Genea Biocells, a preclinical-stage company focused on...

Read More